We evaluated whether the short-term use of dexmedetomidine and propofol may attenuate inflammatory response and improve lung morphofunction in experimental acute lung injury (ALI). Thirty-six Wistar rats were randomly divided into five groups. Control (C) and ALI animals received sterile saline solution and Escherichia coli lipopolysaccharide by intraperitoneal injection respectively. After 24 h, ALI animals were randomly treated with dexmedetomidine, propofol, or thiopental sodium for 1 h. Propofol reduced static lung elastance and resistive pressure and was associated with less alveolar collapse compared to thiopental sodium and dexmedetomidine. Dexmedetomidine improved oxygenation, but did not modify lung mechanics or histology. Propofol was associated with lower IL (interleukin)-6 and IL-1␤ expression, whereas dexmedetomidine led to reduced inducible nitric oxide (iNOS) and increased nuclear factor erythroid 2-related factor 2 (Nrf2) expression in lung tissue compared to thiopental sodium. In conclusion, in this model of mild ALI, short-term use of dexmedetomidine and propofol led to different functional effects and activation of biological markers associated with pulmonary inflammation.
Introduction
Dexmedetomidine and propofol have been used for sedation and short-term surgical procedures in patients with acute respiratory distress syndrome (Choi, 2013; Iapichino et al., 2003; Jin et al., 2013) . Dexmedetomidine has been reported to decrease inflammatory response Yang et al., 2009 ) through a reduction in oxidative stress (Yang et al., 2011 (Yang et al., , 2008 , whereas propofol reduces pulmonary inflammation Yeh et al., 2011) , oxidative stress Tsao et al., 2008) , and apoptosis (Kalimeris et al., 2011) . The immunomodulatory capacity of these agents has been investigated before (Gao et al., 2010; Xu et al., 2013) , at the moment of lung injury induction Yeh et al., 2011) and during long-term use (Chu et al., 2007; Yang et al., 2008) . Furthermore, their effects on lung inflammation depend on timing Taniguchi et al., 2008) and length (Gao et al., 2010) of administration. So far, no study has evaluated their impact on lung morphofunction and molecular biology during short-term use and after the establishment of acute lung injury.
The aim of the present study was to analyze the effects of dexmedetomidine and propofol on lung mechanics, histology, and biological markers associated with pro-and anti-inflammatory activities, fibrogenesis, and oxidative stress in an experimental model of mild acute lung injury during controlled mechanical ventilation in rats.
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Material and methods
This study was approved by the Research Ethics Committee of the Federal University of Rio de Janeiro Health Sciences Centre (CEUA 019). All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the U.S. National Academy of Sciences.
Animal preparation and experimental protocol
Thirty-six female Wistar rats (weight 250-300 g) were used for this study. Thirty rats received Escherichia coli lipopolysaccharide (LPS O55:B5), 1000 g suspended in saline solution to a total volume of 1000 l, by intraperitoneal injection (i.p.) (acute lung injury, ALI). Six rats received saline solution alone (1000 l, i.p.) and constituted the control (C) group. Of the 30 ALI animals, 24 were allocated across three subgroups (n = 8/subgroup). These animals received thiopental sodium (50 mg/kg, i.p.), underwent tail vein cannulation with a 24-gauge polyethylene catheter, and were then randomly assigned to receive: (a) thiopental sodium, 5 mg/kg/h by intravenous infusion; (b) dexmedetomidine, one 5-g bolus over 10 min followed by intravenous infusion at a rate of 0.5 g/kg/h; or (c) propofol by intravenous infusion, at a rate of 100-200 g/kg/min for 10 min and 75-100 g/kg/min thereafter. The infusion rates of propofol and dexmedetomidine were based on previous studies that reported a negligible effect of these anesthetic agents on hemodynamic parameters in septic animals (Chu et al., 2007; Gu et al., 2011; Song et al., 2009; Yang et al., 2008) . Additionally, these infusion rates were adopted to ensure a similar level of anesthesia in all groups. Finally, the whole saline control (C) group (n = 6) and the remaining ALI animals not assigned to any of the three treatment subgroups (n = 6) received thiopental sodium (50 mg/kg i.p.) and were assigned to non-ventilated (NV) groups (C-NV and ALI-NV, respectively) for lung morphometry and molecular biology analysis. C-NV and ALI-NV rats were euthanized 5 min after administration of thiopental sodium so that this anesthetic agent would not affect molecular biology parameters. During spontaneous breathing, the level of anesthesia was assessed by evaluating pupil size, position, and response to light, position of the nictitating membrane, and movement in response to tail stimulation. When an appropriate plane of anesthesia had been achieved, tracheotomy was performed after local anesthesia (lidocaine 1%, subcutaneously). A polyethylene catheter (PE-10) was inserted into the carotid artery for blood sampling and monitoring of mean arterial pressure (MAP). Electrocardiogram (EKG) tracings, MAP, and rectal temperature were continuously recorded (Networked Multi-Parameter Veterinary Monitor LifeWindow TM 6000V, Digicare Animal Health, Florida, USA). Gelafundin ® (B. Braun, Melsungen, Germany) was administered (titrated in 0.5 ml increments), if necessary, to maintain MAP ≥70 mmHg. Pancuronium bromide was then administered (2 mg/kg in the tail vein) to maintain paralysis for 1 h, with an additional bolus equal to half of the initial dose whenever necessary. Lungs were mechanically ventilated (Servo-i, MAQUET, Solna, Sweden) in volume-controlled mode with tidal volume (V T ) = 6 ml/kg, respiratory rate (RR) = 80 breaths/min, fraction of inspired oxygen (FIO 2 ) = 0.4, and zero end-expiratory pressure (ZEEP) during 5 min. Functional data (EKG, MAP, mechanics, and rectal temperature) had been collected (Baseline-ZEEP) to evaluate whether lung mechanical impairment was similar in all ALI groups at the beginning of the experiment. Positive end-expiratory pressure (PEEP) was elevated to 3 cmH 2 O, and functional data measurement repeated. Arterial blood (300 l) was drawn into a heparinized syringe to determine arterial oxygen partial pressure (PaO 2 ) (i-STAT, Abbott Laboratories, Illinois, USA) (Baseline-PEEP). Lung mechanics and PaO 2 were measured after 1 h of mechanical ventilation (End-PEEP). Animals were then euthanized and lungs extracted for histological and molecular biology analysis.
Data acquisition and processing
Airflow, airway (P,aw), and esophageal pressures (Pes) were continuously recorded throughout the experiments with a computer running custom software written in LabVIEW ® (National Instruments; Austin, Texas, USA). Tidal volume (V T ) was calculated by digital integration of the flow signal. Transpulmonary pressure (P,L) was calculated during inspiration and expiration as the difference between P,aw and Pes. All signals were filtered (200 Hz), amplified in a 4-channel signal conditioner (SC-24, SCIREQ, Montreal, Quebec, Canada), and sampled at 200 Hz with a 12-bit analogue-to-digital converter (National Instruments; Austin, Texas, USA). Static lung elastance (Est,L) and resistive pressure ( P1,L) were computed offline by a routine written in MATLAB (Version R2007a; The Mathworks Inc, Natik, Massachusetts, USA) (Santos et al., 2012) .
Lung histology
A laparotomy was performed and heparin (1000 IU) injected into the tail vein. The trachea was clamped at PEEP = 3 cmH 2 O and animals were euthanized by severing the abdominal aorta and vena cava, producing massive hemorrhage and rapid death by exsanguination. Lungs were removed en bloc at the same PEEP level in both groups to avoid distortion of lung morphometry. The right lung was fixed in 3% buffered formaldehyde and embedded in paraffin. Slices (4 m thick) were cut and stained with hematoxylin-eosin.
Lung morphometry was assessed with an integrating eyepiece with a coherent system consisting of a grid with 100 points and 50 lines of known length coupled to a conventional light microscope (OlympusBX51, Olympus Latin America-Inc., Brazil). The volume fractions of the lung occupied by hyperinflated structures (alveolar ducts, alveolar sacs, or alveoli wider than 120 m), collapsed alveoli (alveoli with rough or plicate walls), and normal pulmonary areas (those not presenting overdistended or plicate walls) were determined by the point-counting technique at a magnification of ×200 across 10 random, noncoincident microscopic fields (Weibel, 1990) . To quantify interstitial edema, five arteries were transversely sectioned. The number of points falling on areas of perivascular edema and the number of intercepts between the lines of the integrating eyepiece and the basal membrane of the vessels were counted. The interstitial perivascular edema index was calculated as follows: number of points 1/2 /number of intercepts (Santiago et al., 2010) .
2.4. Biological markers of pro-inflammatory and anti-inflammatory activity, apoptosis, fibrogenesis, oxidative stress, and lung epithelial and endothelial cell damage Quantitative real-time reverse transcription polymerase chain reaction (PCR) was performed to measure biological markers associated with inflammation (interleukin [IL]-6 and IL-1␤), and oxidative stress (inducible nitric oxide synthase [iNOS], endothelial nitric-oxide synthase [eNOS] , and nuclear factor erythroid 2-related factor 2 [Nrf2]). Central slices of the left lung were cut, collected in cryotubes, flash-frozen by immersion in liquid nitrogen, and stored at −80 • C. Total RNA was extracted using the SV Total RNA Isolation System (Promega Corporation, Fitchburg, Wisconsin, USA), following manufacturer recommendations. RNA concentration was measured by spectrophotometry in Nanodrop ND-1000. First-strand cDNA was synthesized from total RNA using the GoTaq® 2-STEP RT qPCR System (Promega Corporation, Fitchburg, Wisconsin, USA). The primers (Integrated DNA Technologies, San Diego, California, USA) used for gene amplification are listed in Table 1 (data online). All samples were measured in triplicate. Relative gene expression was calculated as a ratio of average gene expression levels to the reference gene (36B4) and expressed as fold changes relative to C-NV animals using the 2 − CT method, where CT = CT, reference gene -CT, target gene.
Statistical analysis
Parametric data were expressed as mean ± standard deviation, whereas nonparametric data were expressed as median (interquartile range). One way ANOVA followed by Tukey's test was used to compare lung morphometry and molecular biology data. The Kruskal-Wallis test followed by Dunn's test was used to compare PaO 2 and lung mechanics among different anesthetic agents at Baseline-PEEP and End-PEEP. The Wilcoxon signed-rank test was used to compare PaO 2 and lung mechanics between Baseline-PEEP and End-PEEP. All tests were performed using GraphPad Prism v5.00 (GraphPad Software, La Jolla, California, USA). Significance was established at p < 0.05.
Results
There was no significant difference in MAP among groups and no colloid solution was required to maintain MAP ≥70 mmHg. From Baseline-PEEP to End-PEEP, PaO 2 increased only in the dexmedetomidine group (Fig. 1) , whereas Est,L and P1,L decreased in the propofol group (Fig. 1) . At End-PEEP, P1,L was lower in the propofol than in the dexmedetomidine group, with no significant difference in Est,L among groups.
The fraction area of alveolar collapse was higher in ALI-NV than in C-NV animals, but lower in the propofol than in the ALI-NV and dexmedetomidine groups ( Table 1 ). The degree of interstitial edema was similar in the ALI-NV, thiopental sodium, dexmedetomidine, and propofol groups. Lung hyperinflation and alveolar and airway edema were not observed in ALI animals.
The mRNA expressions of IL-6 and IL-1␤ in lung tissue were higher in ALI-NV than in C-NV animals, and lower in the propofol group than in the ALI-NV and thiopental sodium groups. IL-1␤ expression was reduced to a greater extent in the propofol group than in the ALI-NV, thiopental sodium, and dexmedetomidine groups (Fig. 2) . The mRNA expression of iNOS and eNOS was increased in ALI-NV compared to C-NV animals. iNOS was lower in the dexmedetomidine group than in the thiopental sodium and propofol groups. eNOS was similar in the ALI-NV, thiopental sodium, dexmedetomidine, and propofol groups, whereas, Nrf2 expression was increased only in the dexmedetomidine group (Fig. 3) .
Discussion
In the model of mild ALI in mechanically ventilated rats used in this experiment, we found that short-term (1 h) intravenous administration of dexmedetomidine improved oxygenation, decreased iNOS, and increased Nrf2 mRNA expression, whereas propofol decreased Est,L, P1,L, alveolar collapse, and IL-6 and IL-1␤ mRNA expression in lung tissue. Therefore, propofol and dexmedetomidine yielded different functional effects and led to distinct biomarker expression patterns in this model.
Experimental mild ALI was induced by intraperitoneal injection of E. coli LPS, leading to alveolar collapse, interstitial edema, neutrophil infiltration, and impairment of lung mechanics (Riva et al., 2008) . A protective ventilation strategy with V T = 6 ml/kg and PEEP = 3 cmH 2 O was employed to minimize the influence of possible confounding factors on lung function and molecular biology data. Thiopental sodium was administered to all groups because it is not known to affect the inflammatory process (Giraud et al., 2000) or lung mechanics and morphometry (Correa et al., 2001 ). The animals were not exposed to any nociceptive stimulus, except for tracheotomy, which was performed under local anesthesia.
In our study, propofol led to a reduction in Est,L and P1,L from Baseline-PEEP to END-PEEP. Accordingly, propofol has been previously reported to improve respiratory mechanics in experimental lung injury induced by hepatic ischemia-reperfusion in rats (Chan et al., 2008) and in humans during extracorporeal circulation (Schepp and Reutershan, 2008) . Conversely, dexmedetomidine showed no effects on respiratory mechanics. However, Kastner et al. (2005) observed that dexmedetomidine led to a sustained reduction in dynamic compliance and a significant increase in airway resistance in sheep. These different effects may be attributable to differences in drug dose and infusion duration.
The improvement in Est,L and P1,L in the propofol group may be explained by the presence of smaller fractional area of alveolar collapse and bronchodilation, respectively. In this line, propofol leads to bronchodilation in healthy rats (Peratoner et al., 2004) . The absence of lung morphological and mechanical improvement after dexmedetomidine administration may be associated with an alpha-2 effect on the pulmonary vasculature, yielding increased blood pressure in pulmonary capillaries (Villela and Nascimento Junior, 2003; Kastner et al., 2007) .
Dexmedetomidine, but not propofol, improved oxygenation, which was not related to changes in alveolar collapse. This may be explained by different hypoxic pulmonary vasoconstriction (HPV) responses between dexmedetomidine and propofol. Beck et al. (2001) found that propofol has a weak influence on HPV, whereas Pueyo et al. (1994) reported that, in mechanically ventilated patients undergoing thoracic surgery, continuous infusion of propofol significantly increased shunt and decreased PaO 2 . Conversely, alpha-2 agonists improved oxygenation in dogs undergoing single-lung ventilation, suggesting HPV optimization (Lubbe et al., 1991) . Therefore, it is likely that HPV was less affected by dexmedetomidine than by propofol, resulting in a higher PaO 2 .
Two inflammatory pathways were investigated to evaluate the mechanisms of action of dexmedetomidine and propofol in this experimental study. The first pathway is associated with the inhibition of signaling by NF-kappaB, modulating pro-inflammatory and anti-inflammatory mediators. In our study, a 1-h propofol infusion reduced expression of the pro-inflammatory cytokines IL-6 and IL-1␤, which is consistent with previous studies (Kwak et al., 2004; Tang et al., 2011) . On the other hand, we found that dexmedetomidine did not influence the up-regulation of endotoxin-induced pulmonary inflammatory mediators. This stands in contrast with the findings of previous studies (Yang et al., 2009 (Yang et al., , 2011 (Yang et al., , 2008 that showed an anti-inflammatory effect of dexmedetomidine. The following factors may explain the differences between our study and those reported previously: (1) combination of dexmedetomidine with other anesthetic agents (Yang et al., 2009 (Yang et al., , 2011 ; (2) administration of higher doses, before or immediately after lung damage induction (Jiang et al., 2014) ; (3) longer duration of infusion ; and (4) use of different models of lung injury (Jiang et al., 2014) .
The second pathway is associated with mechanisms related to oxidative stress. In this line, the transcription factor Nrf2, the antioxidant enzyme iNOS, and the constitutive NOS isoform expressed mainly in endothelial cells (eNOS) were measured. Nrf2 regulates antioxidant defenses that protect against inflammation by inhibiting oxidative tissue injury (Cho et al., 2006; Kong et al., 2011) . To our knowledge, the influence of propofol, dexmedetomidine, and thiopental sodium on Nrf2 expression in acute lung inflammation has not been investigated. We found that dexmedetomidine increased Nrf2 expression in lung tissue as compared with the other agents tested, suggesting its possible role in reducing lung inflammation. iNOS is expressed in various types of lung cells in response to pathogens (Dias-Junior et al., 2008) . In ALI-NV animals, both iNOS and eNOS expression were increased as compared with C-NV animals, which is consistent with previous studies (Farley et al., 2006; Lange et al., 2010; Razavi et al., 2004) . iNOS expression was reduced in the dexmedetomidine group compared to the ALI-NV and thiopental sodium groups, which may be attributed to the high dose used in the present study to keep animals pain-free and relaxed. In this context, a previous study showed a dose-dependent action of dexmedetomidine on oxidative stress (Yang et al., 2008) . Propofol led to a reduction in iNOS compared to ALI-NV, but no significant decrease was observed in iNOS compared to the thiopental sodium group; again, this is consistent with previous studies . There were no significant differences in eNOS expression across the thiopental sodium, propofol, dexmedetomidine, and ALI-NV groups. However, a previous study (Gao et al., 2006) found that propofol reduced eNOS mRNA expression. This difference may be related to: (1) distinct propofol infusion protocols; (2) different observation time; and (3) timing of propofol infusion (in most studies, the infusion is started before induction of lung injury). Dexmedetomidine and propofol are commonly used for shortterm anesthesia and procedural sedation in patients with acute lung injury. Our data suggest that, in an animal model of mild ALI, both dexmedetomidine and propofol reduced biological markers of inflammation in lung tissue. However, due to their different functional effects, dexmedetomidine might be indicated in patients with hypoxemia, whereas propofol might be better suited in patients with clinical bronchoconstriction.
The present study has some limitations. Our results cannot be extrapolated to other experimental models of ALI, with different severities and ventilator strategies, or to the clinical setting. The observation time was relatively short (1 h of mechanical ventilation), precluding extrapolation of our findings to longer periods of ventilation. The expression of mediators was quantified using RT-PCR instead of ELISA. It is well known that 1 h is sufficient time to produce changes in mRNA expression, but not to significantly change protein levels (Vogel and Marcotte, 2012) . The dose of dexmedetomidine used in the present study was higher than that commonly used in clinical practice. However, the pharmacokinetics of this agent differ in rats and humans due to rapid metabolism (Bol et al., 1997; Villela and Nascimento Junior, 2003) , and our aim was to keep the animals anesthetized.
Conclusions
In the model of mild ALI used herein, short-term administration of dexmedetomidine and propofol led to different functional effects and activation of biological markers associated with pulmonary inflammation. The present study may be considered as a first step for developing other experimental and clinical studies to evaluate the short-term effects of propofol and dexmedetomidine in ALI.
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